| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5733770 | Journal of Surgical Research | 2017 | 8 Pages |
Abstract
Independent of AT utilization and biologic factors, PMC negatively impacted OS in patients treated with surgery first. These data suggest that strategies to decrease PMC and treatment sequencing alternatives to increase multimodality therapy rates may improve oncologic outcomes for PDAC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Anh-Thu MD, Bin DrPH, Dima MD, Hayder MD, Sean P. MD, Peter J. MD, Eric B. DrPH, Mahesh MD, Patrick C. MD, Ching-Wei D. MD,